Search

everythinglearnresearchcommunity

for

Search:↓

Injecting hyaluronidase into the artery is effective for treating skin death and hair loss caused by hyaluronic acid fillers.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Unsatisfactory hair restoration results can be significantly improved with strategic hair redistribution and new donor hair placement, despite previous surgery challenges.

Pressure-induced hair loss is rare, often reversible, and early diagnosis is crucial to prevent complications.

Filler injections can cause temporary hair loss, but hyaluronidase can help restore hair within a few months.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Prolactin may affect hair growth differently based on gender and scalp area.

The effects of estrogen on human hair growth are unclear and need more research.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Hair follicles prevent NK cell attacks to avoid hair loss.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

A 5-year-old boy was diagnosed with congenital triangular alopecia, a type of hair loss without skin changes, usually starting between ages 2-5, with no specific treatment.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Temporal triangular alopecia usually starts in early childhood and treatment with Minoxidil has limited effectiveness.

The document concludes that a woman has both Frontal Fibrosing Alopecia and Lichen Simplex Chronicus, a previously unreported combination of conditions.

The woman has a type of scarring hair loss with red bumps around hair follicles.

Isotretinoin at low doses effectively treats facial papules in frontal fibrosing alopecia.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

A 14-year-old boy was diagnosed with a rare hair condition that may lead to hair thinning and has no known effective treatments.

The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.

Methotrexate may help stabilize frontal fibrosing alopecia.